Erythropoietin-receptor expression and function during the initiation of murine yolk sac erythropoiesis.
Although erythropoietin is necessary for definitive (fetal liver and bone marrow) erythropoiesis, the role of erythropoietin signaling in primitive (yolk sac) hematopoiesis has not been well defined. In situ hybridization studies have revealed that erythropoietin-receptor (EPOR) mRNA accumulation begins in mesoderm cell masses of the developing yolk sac of the neural plate stage embryo (E7.5) before the development of morphologically recognizable erythroblasts. EPOR mRNA is also present in yolk sac blood islands at early somite stages (E8.5). These findings suggest that EPOR functions during early stages of yolk sac erythropoiesis. We have used a serum-free murine yolk sac explant system (Palis et al., Blood 86:156, 1995) to investigate the initial differentiation of primitive erythroblasts from extraembryonic mesoderm cells. Exogenous erythropoietin increased both erythroblast numbers and betaH1-globin accumulation in yolk sac explants, suggesting that primary yolk sac erythroblasts are directly responsive to erythropoietin. An antisense oligodeoxynucleotide (ODN) experimental approach was used to examine the functional role of erythropoietin signaling during the initiation of yolk sac hematopoiesis in yolk sac explants. Antisense EPOR ODN produced a >50% reduction (p < 0.005) in the number of differentiating primitive erythroblasts, >95% reduction in betaH1-globin accumulation (p < 0.001), and a >50% reduction (p < 0.01) in the number of CFU-E and BFU-E compared with missense EPOR ODN-treated and untreated control explants. Antisense EPOR ODN also blocked the increase in primitive erythroblast number induced by exogenous erythropoietin. We conclude that erythropoietin/EPOR signaling is functionally active during the initial proliferation and differentiation of primary yolk sac erythroblasts. These results also suggest that other growth factor signaling cascades are active during the onset of mammalian erythropoiesis.
McGann
J K
JK
Department of Pediatrics, University of Rochester Medical Center, NY 14642, USA.
Silver
L
L
Liesveld
J
J
Palis
J
J
D000818:Animals; D003114:Colony-Forming Units Assay; D004622:Embryo, Mammalian / Q000502:physiology*; D005314:Embryonic and Fetal Development; D004900:Erythroblasts / Q000166:cytology / Q000502:physiology; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D018507:Gene Expression Regulation, Developmental; D005914:Globins / Q000096:biosynthesis*; D006410:Hematopoiesis / Q000187:drug effects / Q000502:physiology; D051379:Mice; D008813:Mice, Inbred ICR; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D009924:Organ Culture Techniques; D017467:Receptors, Erythropoietin / Q000096:biosynthesis* / Q000187:drug effects / Q000502:physiology; D015017:Yolk Sac / Q000502:physiology*
D016376:Oligonucleotides, Antisense; D017467:Receptors, Erythropoietin; D005914:Globins